For instance, studies have highlighted the significance of RNA methylation regulators like METTL3 and ALKBH5 in shaping tumor behavior by modulating m6A RNA modifications, providing promising avenues for BLCA treatment25,26. The gene discussed is METTL3; the disease is bladder transitional cell carcinoma.